Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease

Moyamoya disease (MMD) and moyamoya syndrome (MMS) are progressive vascular pathologies unique to the cerebrovasculature that are important causes of stroke in both children and adults. The natural history of MMD is characterized by primary progressive stenosis of the supraclinoid internal carotid a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brandon M. Fox, Kirsten B. Dorschel, Michael T. Lawton, John E. Wanebo
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/642bfd1796474753b1d005dab2a0ced0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:642bfd1796474753b1d005dab2a0ced0
record_format dspace
spelling oai:doaj.org-article:642bfd1796474753b1d005dab2a0ced02021-12-01T08:41:19ZPathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease1664-229510.3389/fneur.2021.661578https://doaj.org/article/642bfd1796474753b1d005dab2a0ced02021-09-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.661578/fullhttps://doaj.org/toc/1664-2295Moyamoya disease (MMD) and moyamoya syndrome (MMS) are progressive vascular pathologies unique to the cerebrovasculature that are important causes of stroke in both children and adults. The natural history of MMD is characterized by primary progressive stenosis of the supraclinoid internal carotid artery, followed by the formation of fragile collateral vascular networks. In MMS, stenosis and collateralization occur in patients with an associated disease or condition. The pathological features of the stenosis associated with MMD include neointimal hyperplasia, disruption of the internal elastic lamina, and medial attenuation, which ultimately lead to progressive decreases in both luminal and external arterial diameter. Several molecular pathways have been implicated in the pathophysiology of stenosis in MMD with functions in cellular proliferation and migration, extracellular matrix remodeling, apoptosis, and vascular inflammation. Importantly, several of these molecular pathways overlap with those known to contribute to diseases of systemic arterial stenosis, such as atherosclerosis and fibromuscular dysplasia (FMD). Despite these possible shared mechanisms of stenosis, the contrast of MMD with other stenotic pathologies highlights the central questions underlying its pathogenesis. These questions include why the stenosis that is associated with MMD occurs in such a specific and limited anatomic location and what process initiates this stenosis. Further investigation of these questions is critical to developing an understanding of MMD that may lead to disease-modifying medical therapies. This review may be of interest to scientists, neurosurgeons, and neurologists involved in both moyamoya research and treatment and provides a review of pathophysiologic processes relevant to diseases of arterial stenosis on a broader scale.Brandon M. FoxKirsten B. DorschelMichael T. LawtonJohn E. WaneboFrontiers Media S.A.articleangiopathycerebrovascularmoyamoyastenosisstrokeNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic angiopathy
cerebrovascular
moyamoya
stenosis
stroke
Neurology. Diseases of the nervous system
RC346-429
spellingShingle angiopathy
cerebrovascular
moyamoya
stenosis
stroke
Neurology. Diseases of the nervous system
RC346-429
Brandon M. Fox
Kirsten B. Dorschel
Michael T. Lawton
John E. Wanebo
Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
description Moyamoya disease (MMD) and moyamoya syndrome (MMS) are progressive vascular pathologies unique to the cerebrovasculature that are important causes of stroke in both children and adults. The natural history of MMD is characterized by primary progressive stenosis of the supraclinoid internal carotid artery, followed by the formation of fragile collateral vascular networks. In MMS, stenosis and collateralization occur in patients with an associated disease or condition. The pathological features of the stenosis associated with MMD include neointimal hyperplasia, disruption of the internal elastic lamina, and medial attenuation, which ultimately lead to progressive decreases in both luminal and external arterial diameter. Several molecular pathways have been implicated in the pathophysiology of stenosis in MMD with functions in cellular proliferation and migration, extracellular matrix remodeling, apoptosis, and vascular inflammation. Importantly, several of these molecular pathways overlap with those known to contribute to diseases of systemic arterial stenosis, such as atherosclerosis and fibromuscular dysplasia (FMD). Despite these possible shared mechanisms of stenosis, the contrast of MMD with other stenotic pathologies highlights the central questions underlying its pathogenesis. These questions include why the stenosis that is associated with MMD occurs in such a specific and limited anatomic location and what process initiates this stenosis. Further investigation of these questions is critical to developing an understanding of MMD that may lead to disease-modifying medical therapies. This review may be of interest to scientists, neurosurgeons, and neurologists involved in both moyamoya research and treatment and provides a review of pathophysiologic processes relevant to diseases of arterial stenosis on a broader scale.
format article
author Brandon M. Fox
Kirsten B. Dorschel
Michael T. Lawton
John E. Wanebo
author_facet Brandon M. Fox
Kirsten B. Dorschel
Michael T. Lawton
John E. Wanebo
author_sort Brandon M. Fox
title Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
title_short Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
title_full Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
title_fullStr Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
title_full_unstemmed Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
title_sort pathophysiology of vascular stenosis and remodeling in moyamoya disease
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/642bfd1796474753b1d005dab2a0ced0
work_keys_str_mv AT brandonmfox pathophysiologyofvascularstenosisandremodelinginmoyamoyadisease
AT kirstenbdorschel pathophysiologyofvascularstenosisandremodelinginmoyamoyadisease
AT michaeltlawton pathophysiologyofvascularstenosisandremodelinginmoyamoyadisease
AT johnewanebo pathophysiologyofvascularstenosisandremodelinginmoyamoyadisease
_version_ 1718405357534969856